
In addition to Thompson joining the board of directors, EyeCool also announced the members joining its newly formed medical advisory board (MAB).

Neurotrophic keratitis outcomes improve with early, stage-based care

In addition to Thompson joining the board of directors, EyeCool also announced the members joining its newly formed medical advisory board (MAB).

Hidden signs of systemic disease, including heart attacks, may first reveal themselves through visual symptoms or subtle patient cues in the exam chair.


Timely diagnosis and personalized treatment are key to improving visual outcomes.



This population requires careful attention from diagnosis through the entire postoperative process.

Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision.

This year was brimming with advancements in eye care.

At the Tear Film and Ocular Surface meeting in Venice, Melissa Toyos shares findings on the mechanism of action of brimonidine tartrate.

Common glaucoma treatments may worsen ocular surface disease and meibomian gland dysfunction, leading to discomfort, redness, and even poor treatment compliance.

The team conducted a cross-sectional study from December 2016 to March 2024 in patients with acute infectious conjunctivitis


All patients included in the study had been referred to Ocular Oncology Service of the Federal University of São Paulo with the suspicion of ocular metastasis.

The module encompasses real world data on more than 250,000 de-identified patients and provides information on extracting diagnoses from clinical notes in electronic health records.

Pterygium is an ocular disease commonly referred to as “surfer’s eye,” which can result from exposure to high levels of UV radiation.

While the change is mostly a result of improved recognition of in situ cases, authors wanted to identify any changes in the incidence and mortality of conjunctival melanoma in Australia from 1982 to 2014.

Alice Epitropoulos, MD, discusses the importance of considering ocular surface health in cataract surgery patients.

This NDA transfer marks the fourth FDA-approved ophthalmic product purchased by Harrow earlier in 2023 now commercially available in the US.

Surgeon details training, experience with procedure that offers hope to patients.

Esen Akpek, MD, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss ocular surface disease and the lifestyle choices that could affect eye health. As well as what The Tear Film & Ocular Surface Society is doing to promote research on the topic.

Eye rubbing is a common practice, but one that can cause a number of problems.

Alice Epitropoulos, MD, goes over some tips and methods to educate patients about OSD before performing any surgery.

Patients treated with azithromycin did not have a higher incidence of gastrointestinal adverse events.

Outcomes achieved with information, osmolarity testing, proven treatments